CD4 and neoplasm: Similarly, a reduction in CD4+CD25+ T cells was observed when DC2.4 cells were exposed to Py230 tumor antigens with ADMA treatment (Figure 5C), while the CD8+CD25+ T cell population remained unchanged (Figure 5D).